Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Takeshi Horii

Comparing Treatment Intensification and Clinical Outcomes of Metformin and Dipeptidyl Peptidase‐4 Inhibitors in Treatment Naïve Patients With Type 2 Diabetes in Japan

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Development of a Portable Bruxism Monitoring and Analysis Device Equipped With a Microcomputer and Its Practical Application

Frontiers of Medical and Biological Engineering
2001English

Related publications

Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2007English

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus

Frontiers in Pharmacology
Pharmacology
2017English

The Old and the New in the Treatment of Type 2 Diabetes: Focus on the Combination Therapy With Dipeptidyl Peptidase-4 Inhibitors and Metformin

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Acquired Hemophilia a Associated With Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients With Type 2 Diabetes

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

2011English

Effectiveness in Clinical Practice Versus Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Clinical Trials for Type 2 Diabetes: Protocol for Systematic Review

BMJ Open
Medicine
2019English

Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy